Logo

American Heart Association

  141
  0


Final ID: Mo015

Myeloid Specific PD-L1 Deletion Promotes Cardiac Dysfunction And Myocardial Inflammation

Abstract Body: Background: Immunotherapy, particularly PD-1/PD-L1 blockers, is effective in cancer treatment but can cause rare, but potentially fatal heart issues. Despite the significant impact of these adverse events, there is limited research into the underlying mechanisms of immune checkpoint inhibitor (ICI)-mediated cardiotoxicity. PD-L1, which is abundantly expressed in cardiac tissue, particularly exhibits high expression levels over myeloid cells. However, the precise role of myeloid-specific PD-L1 signaling in mediating autoimmune cardiac disease pathology remains unclear.
Methods and Results: To study the role of myeloid cell-specific PD-L1 (myeloid-PD-L1) in cardiac pathophysiology, we generated myeloid-specific PD-L1 KO mice, using Lyz2tm1(Cre) Ifo systems. As expected, PD-L1 expression was significantly down-regulated in Mφs from myeloid-PD-L1 KOs. The cardiac function was followed by echocardiography. Controls and myeloid-PD-L1-KO hearts had comparable ventricular function at 1 month of age. Interestingly, as early as 2 months of age, myeloid-PD-L1-KOs displayed marked cardiac dysfunction as reflected by reduced LVEF, LVFS, and HF markers. Immune profiling was conducted whether chronic inflammation contributes to cardiac dysfunction and remodeling at a later age as observed at 2 and 3 months of age. Interestingly, excessive systemic inflammation and substantial immune infiltration (innate and adoptive), activation, and a pro-inflammatory cytokine storm were detected in the KO hearts. Furthermore, myeloid-PD-L1 KO hearts showed increased recruitment of pro-inflammatory CCR2+ monocytes and macrophages.
Conclusion: Our data with myeloid-PD-L1 KOs suggest that deleting PD-L1 in myeloid lineage promotes myocardial and systemic inflammation through innate and adaptive immune cell activation and recruitment of CCR2+ MΦs. Subsequently, this leads to impaired cardiac pathophysiology. Thus, these translational studies will directly evaluate the potential of targeting myeloid-PD-L1 signaling to alleviate cardiac damage.
  • Toro Cora, Angelica  ( UAB , Birmingham , Alabama , United States )
  • Sethi, Rohan  ( UAB , Birmingham , Alabama , United States )
  • Zhang, Qinkun  ( UAB , Birmingham , Alabama , United States )
  • Lal, Hind  ( UAB , Birmingham , Alabama , United States )
  • Sultan, Tousif  ( UAB , Birmingham , Alabama , United States )
  • Author Disclosures:
    Angelica Toro Cora: DO NOT have relevant financial relationships | Rohan Sethi: No Answer | qinkun zhang: DO NOT have relevant financial relationships | Hind Lal: DO NOT have relevant financial relationships | Tousif Sultan: No Answer
Meeting Info:

Basic Cardiovascular Sciences

2024

Chicago, Illinois

Session Info:

Poster Session and Reception I

Monday, 07/22/2024 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
A mechanism whereby SGLT2 inhibitor dapagliflozin reverses cardiac diastolic dysfunction in a model of HFpEF

Liu Man, Liu Hong, Kang Gyeoung-jin, Kim Eunji, Neumann Mitchell, Johnson Madeline, Murikinati Ruthvika, Dudley Samuel

A20 in the Kidney Epithelium Attenuates Angiotensin II-induced Hypertension by Constraining Renal Tubular NHE3 Expression

Lu Xiaohan, Ren Jiafa, Wen Yi, Griffiths Robert, Yang Ting, Hammer Gianna, Zhuo Jia, Crowley Steven

More abstracts from these authors:
Cardiomyocytes HIPK2 Regulates Myocardial Inflammation And Heart Function Through Purinergic Signaling

Sultan Tousif, Krishnamurthy Prasanna, Lal Hind, Umbarkar Prachi, Sethi Rohan, Toro Cora Angelica, Chen Yunxi, He Jin, Dubey Praveen, Zhang Qinkun, Xie Min

+Myeloid-derived Immunosuppressive PD-1/PD-L1 Signaling is Essential to Maintain Adult Heart Homeostasis

Toro Cora Angelica, Bhati Arvind, Li Daniel, Sethi Rohan, Zhang Qinkun, Lal Hind, Sultan Tousif

You have to be authorized to contact abstract author. Please, Login
Not Available